TY - JOUR
T1 - Urinary phthalate metabolites and ovarian reserve among women seeking infertility care
AU - Messerlian, Carmen
AU - Souter, Irene
AU - Gaskins, Audrey J.
AU - Williams, Paige L.
AU - Ford, Jennifer B.
AU - Chiu, Yu Han
AU - Calafat, Antonia M.
AU - Hauser, Russ
N1 - Funding Information:
The authors gratefully acknowledge Manori Silva, Ella Samandar, Jim Preau and Tao Jia (CDC, Atlanta, GA) for measuring the urinary concentrations of the phthalate metabolites.We also acknowledge all members of the EARTH study team, specifically the Harvard T. H. Chan School of Public Health research nurses Jennifer B. Ford and Myra G. Keller, research staff RamaceDadd and Patricia Morey, physicians and staff at Massachusetts General Hospital FertilityCenter and a special thanks to all the study participants. Work supported by grants ES009718, ES022955, ES000002, and T32ES007069 from the National Institute of Environmental Health Sciences (NIEHS) and grant T32 DK007703-16 from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). C.M. was supported by a post-doctoral trainingaward from the Canadian Institutes of Health Research. The authors haveno conflict of interests to declare. The findings and conclusions in this report are those of the authors and do not necessarily represent the views of the Centers for Disease Control and Prevention (CDC). The use of trade names and commercial sources is for identification only and does not constitute endorsement by the US Department of Health and Human Services or CDC.
Publisher Copyright:
© The Author 2015.
PY - 2016/1/1
Y1 - 2016/1/1
N2 - Study question: Are urinary phthalate metabolites associated with reduced antral follicle growth among women in an infertility setting? summary answer: Higher urinary concentrations of di(2-ethylhexyl) phthalate (DEHP) metabolites were associated with significant decreases in antral follicle count (AFC) among women seeking infertility care. what is known already: Experimental animal studies show that DEHP accelerates primordial follicle recruitment and inhibits antral follicle growth. Whether phthalates also reduce the growing antral follicle pool in humans remains unknown. study design, size, duration:We examined the association between urinary phthalate metabolites andAFCusing prospective data from 215 females recruited between 2004 and 2012 in the Environment and Reproductive Health (EARTH) study. participants/materials, setting, methods: We quantified the urinary concentrations of 11 phthalate metabolites. We estimated the geometric mean for all urine samples provided prior to unstimulated day 3 AFC assessment for each woman.We evaluated the association of AFC withΣDEHP (molar sum of four DEHP metabolites) and individual phthalate metabolites using Poisson regression, adjusting for age, BMI and smoking. main results and the role of chance: We observed significant decreases in mean AFC for all higher quartiles ofΣDEHP as compared with the lowest quartile. Compared with women in the first quartile ofΣDEHP, women in the second, third and fourth quartiles had a 224% (95% confidence interval (CI): -32%, -16%), -19% (95% CI: -27%, 29%), and214% (95% CI: -23%, -5%) decrease in mean AFC. The absolute mean AFC in the first quartile was 14.2 follicles (95% CI: 13.2, 15.2) compared with 10.7 follicles (95% CI: 9.9, 11.6) in the second quartile.We observed similar trends among the four individual DEHP metabolites. There was no consistent change in AFC among the remaining phthalate metabolite concentrations evaluated. limitations, reasons for caution: We demonstrated a negative association between DEHP and a well-established marker of ovarian reserve among a subfertile population. However these findings may not be generalizable to women without fertility concerns, and we cannot rule out co-exposure to other chemicals. wider implications of the findings: Environmental chemicals that inhibit the size of the growing antral follicle pool can impair fertility and reduce fecundity. This study suggests evidence in need of further investigation on the impact of phthalates on the human oocyte and follicular development. study funding/competing interests:Work supported by grants ES009718, ES022955, ES000002, and T32ES007069 fromthe National Institute of Environmental Health Sciences (NIEHS) and grant T32 DK007703-16 from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). C.M. was supported by a post-doctoral training award from the Canadian Institutes of Health Research. There are no competing interests to declare.
AB - Study question: Are urinary phthalate metabolites associated with reduced antral follicle growth among women in an infertility setting? summary answer: Higher urinary concentrations of di(2-ethylhexyl) phthalate (DEHP) metabolites were associated with significant decreases in antral follicle count (AFC) among women seeking infertility care. what is known already: Experimental animal studies show that DEHP accelerates primordial follicle recruitment and inhibits antral follicle growth. Whether phthalates also reduce the growing antral follicle pool in humans remains unknown. study design, size, duration:We examined the association between urinary phthalate metabolites andAFCusing prospective data from 215 females recruited between 2004 and 2012 in the Environment and Reproductive Health (EARTH) study. participants/materials, setting, methods: We quantified the urinary concentrations of 11 phthalate metabolites. We estimated the geometric mean for all urine samples provided prior to unstimulated day 3 AFC assessment for each woman.We evaluated the association of AFC withΣDEHP (molar sum of four DEHP metabolites) and individual phthalate metabolites using Poisson regression, adjusting for age, BMI and smoking. main results and the role of chance: We observed significant decreases in mean AFC for all higher quartiles ofΣDEHP as compared with the lowest quartile. Compared with women in the first quartile ofΣDEHP, women in the second, third and fourth quartiles had a 224% (95% confidence interval (CI): -32%, -16%), -19% (95% CI: -27%, 29%), and214% (95% CI: -23%, -5%) decrease in mean AFC. The absolute mean AFC in the first quartile was 14.2 follicles (95% CI: 13.2, 15.2) compared with 10.7 follicles (95% CI: 9.9, 11.6) in the second quartile.We observed similar trends among the four individual DEHP metabolites. There was no consistent change in AFC among the remaining phthalate metabolite concentrations evaluated. limitations, reasons for caution: We demonstrated a negative association between DEHP and a well-established marker of ovarian reserve among a subfertile population. However these findings may not be generalizable to women without fertility concerns, and we cannot rule out co-exposure to other chemicals. wider implications of the findings: Environmental chemicals that inhibit the size of the growing antral follicle pool can impair fertility and reduce fecundity. This study suggests evidence in need of further investigation on the impact of phthalates on the human oocyte and follicular development. study funding/competing interests:Work supported by grants ES009718, ES022955, ES000002, and T32ES007069 fromthe National Institute of Environmental Health Sciences (NIEHS) and grant T32 DK007703-16 from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). C.M. was supported by a post-doctoral training award from the Canadian Institutes of Health Research. There are no competing interests to declare.
UR - http://www.scopus.com/inward/record.url?scp=84957604412&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84957604412&partnerID=8YFLogxK
U2 - 10.1093/humrep/dev292
DO - 10.1093/humrep/dev292
M3 - Article
C2 - 26573529
AN - SCOPUS:84957604412
SN - 0268-1161
VL - 31
SP - 75
EP - 83
JO - Human Reproduction
JF - Human Reproduction
IS - 1
ER -